Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITONAVIR vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITONAVIR vs RIVAROXABAN: Safety Overview

Metric RITONAVIR RIVAROXABAN
Total FAERS Reports 11,980 131,274
Deaths Reported 1,190 19,233
Death Rate 9.9% 14.7%
Hospitalizations 2,925 70,513
Average Patient Age 43.8 yrs 70.0 yrs
% Female Patients 43.8% 47.7%
FDA Approval Date Dec 3, 2020 Apr 10, 2025
Manufacturer AbbVie Inc. Macleods Pharmaceuticals Limited
Route ORAL ORAL
Marketing Status Discontinued Prescription